Patients w/ asthma; severe CV disease; urinary retention or narrow-angle glaucoma; convulsive disorders or thyrotoxicosis, & in patients who are unusually responsive to β2-adrenergic agonists. Discontinue if paradoxical bronchospasm occurs. Not for treatment of acute episodes of bronchospasm. In the event of COPD deterioration during treatment, re-evaluate patient & treatment regimen. In concomitant w/ other drugs that have the potential to cause hypokalaemia. Monitor plasma glucose in diabetic patients. Rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. Severe hepatic impairment. Pregnancy & lactation.
R03AL03 - vilanterol and umeclidinium bromide ; Belongs to the class of combination of adrenergics with anticholinergics, that may also include a corticosteroid. Used in the treatment of obstructive airway diseases.
Sign Out
